Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of AVITA Medical, Inc. (NASDAQ: RCEL) resulting from allegations that AVITA Medical may have issued materially misleading business information to the investing public.
If you purchased AVITA Medical securities and would like to join the prospective action, please click “Join This Class Action.”
On October 16, 2025, after market close, AVITA Medical issued a press release called “AVITA Medical Announces CEO Transition.” It stated that the Company had “effective immediately,” named an Interim Chief Executive Officer and that in “conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board.”
On this news, AVITA Medical stock fell 25.8% on October 17, 2025.
The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.
Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.
Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.
The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.
